Description: Hydroxylation of P405 in the VHL-binding motif of Endothelial PAS domain-containing protein 1 (EPAS1) induces binding to the Von Hippel-Lindau disease tumor suppressor (VHL) protein.
Participants: (1) Endothelial PAS domain-containing protein 1 (EPAS1) (2) Von Hippel-Lindau disease tumor suppressor (VHL)
(1) Inhibition of HIF2alpha is sufficient to suppress pVHL-defective tumor growth.Kondo et al. PLoS Biol. (2003) (2) Characterization of the human prolyl 4-hydroxylases that modify the hypoxia-inducible factor.Hirsilä et al. J. Biol. Chem. (2003)
Other switches involving participantsVon Hippel-Lindau disease tumor suppressor (VHL) - 5 more (view)Endothelial PAS domain-containing protein 1 (EPAS1) - 1 more (view)Other switches involving interfacesDEG_ODPH_VHL_1 - 5 more (view)von Hippel-Lindau disease tumour suppressor protein - 5 more (view)
Your browser does not support iframes.